← Back to headlines

Greeks to wait over 2 years for new innovative medicines
A new bill in Greece is causing delays of over two years for patients to access innovative medicines, due to changes in country selection for drug availability and a lack of three-year funding projections for the Innovation Fund.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


